White Paper

Unique First-in-Human Phase I IRB Considerations you Might not Know About

An institutional review board (IRB) may ask some different questions for first-in-human (FIH) Phase I trials than later phase studies.

Our white paper helps address these questions, explaining why:

  • Informed consent form (ICF) revisions must be implemented quickly
  • IRB experience in Phase I is vital to properly protecting participants
  • FIH studies sometimes feature more robust payments and incentives
  • House rules are important for everyone’s safety

Download the white paper.

Who Should Watch?

CEU Credits

Certificate of Attendance

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Download Now